https://www.youtube.com/watch?v=JcZuUt8jXBI The average survival of patients with idiopathic pulmonary fibrosis (IPF) is between three and five years after diagnosis, and only 20% of them survive past this time. Like many others, Anita Hatfield struggled for three years with the disease and died last March from complications related to idiopathic pulmonary fibrosis.
IPF Testimony: Jim Hatfield Continues his Wife’s Legacy
Efficacy and Safety of Nintedanib (Ofev), an IPF Drug, Confirmed in New Analyses of Phase 3 Trials
New analyses, presented at the American Thoracic Society (ATS) 2016 Annual Conference, further support the efficacy and safety of nintedanib (Ofev) in treating idiopathic pulmonary fibrosis (IPF). Boehringer Ingelheim shared a host of data at the meeting, establishing nintedanib as an important player in IPF management, irrespective of disease severity. “IPF…
Renate Huebner was diagnosed with pulmonary fibrosis at the age of 65 in August 2012. With 10 children and 38 grandchildren, Renate’s large family didn’t quite understand the disease at first. Now, after her death a year ago, the family is focused on the project Give Air and continuing the matriarch’s…
https://www.youtube.com/watch?v=tnjwJTTVmKs&feature=youtu.be Living with a chronic illness means that not all days are good days. Sometimes you wake up feeling unwell but still have to get on and do things, leave your house and face the day. To help you through those rough days, Lauren from …
https://www.youtube.com/watch?v=sB71s2_klbA I Am News, a local community news project from Swansea, UK, shared this video where you can meet Margaret Marsh. Margaret is an idiopathic pulmonary fibrosis patient, a member of the British Lung Foundation and Chair of Chepstow Breathe Easy Group. In this video, she…
While living with a serious rare lung condition such as pulmonary fibrosis, it is understandable that several doubts and questions about it may come up. In this video, shared by Demystifying Medicine, learn more about some important questions regarding pulmonary fibrosis. Is PF the…
Netrin-1, a factor produced by the extracellular matrix, drives the production and accumulation of fibrocytes, a fibrosis-promoting cell type in patients with systemic sclerosis (SSc)-induced pulmonary fibrosis, according to a study by Yale University School of Medicine researchers. Fibrocytes are cells that often reside in the extracellular matrix —…
https://www.youtube.com/watch?v=QZjVxgHXR8E I Am News, a local community news project from Swansea, UK, shared this video where you can meet Margaret Barnard. Margaret is a chronic obstructive pulmonary disease patient, a member of the British Lung Foundation and Breathe Easy Group. In this video, she shares a little bit…
What are Stem Cells and How Can They Be Used?
You’ve probably already heard about stem cells and their healing power. Several disease can be treated by using stem cells treatments and therapies, pulmonary fibrosis being one of them. But what exactly are stem cells and how can they be so versatile to be able to be used as…
A Patient’s Life with IPF: A Fresh Start
In this recent line of videos by this father of two named Mark, we are presented with his story of resilience and strength. In 2014, his health was rapidly declining and he found himself bedridden for most of the year because of the deterioration in his lung functions due to…
Your PF Community
Recommended Posts
- I’m living proof of the profound impact of organ donation
- From diagnosis to treatment: What life with PF is like, part 2
- New generic of Ofev for IPF approved by FDA, slated for ‘immediate’ launch
- Working to bring the PF and broader ILD communities together
- 4 navigation tools that guided me on my journey with IPF
